To focus its development activities on topics that are more closely linked to its core business, Bayer MaterialScience is bringing its work on carbon nanotubes (CNTs) to a close.
The company says that their researchers had collaborated with external partners in recent years to resolve complex issues relating to the safe production of specific carbon nanotubes. Methods for scaling up the production processes were developed, as were new generations of catalysts and new types of products.
Much of the knowledge gleaned over recent years was made available to other companies and research institutions within the Innovation Alliance Carbon Nanotubes (Inno.CNT), which counts Bayer MaterialScience among its roughly 90 members.
“We remain convinced that carbon nanotubes have huge potential,” says Patrick Thomas, Chief Executive Officer of Bayer MaterialScience. It has been found, however, that the potential areas of application that once seemed promising from a technical standpoint are currently either very fragmented or have few overlaps with the company’s core products and their application spectrum.
“For Bayer MaterialScience, ground breaking applications for the mass market relating to our own portfolio and therefore comprehensive commercialisation are not likely in the foreseeable future,” says Thomas. Nonetheless, this know-how provides an important basis for a possible later use of CNT, for example in the optimisation of lithium ion batteries, Thomas says. “We are currently in contact with potential interested parties regarding the specific application of the know-how generated,” Thomas adds.
The conclusion of the nano projects has no impact on the headcount. All 30 people employed in this sector will be transferred to other suitable positions within the Group.
For more information visit:
Subscribe to receive our weekly round-up of all the industry's latest news, jobs, events and more!